iPSC model helps to better understand genetic lung/liver disease
Thursday, April 2, 2015 - 13:30
in Health & Medicine
Using patient-derived stem cells known as induced pluripotent stem cells (iPSC) to study the genetic lung/liver disease called alpha-1 antitrypsin deficiency, researchers have for the first time created a disease signature that may help explain how abnormal protein leads to liver disease.